Products
Curatis is passionate about enabling specialist healthcare professionals to treat patients who have rare diseases, specialty care diseases and intoxications.
Curatis markets and distributes medicines for the treatment and/or prevention of orphan and specialty diseases in Switzerland. Curatis currently holds exclusive distribution rights for 40+ products and has set the goal of significantly increasing the number of third-party drugs under contract.
In addition, Curatis aims to secure distribution rights for drugs in major European markets: Germany, France, United Kingdom, Italy.
Product Catalogue
SPC = Summary of Product Characteristics · PIL = Patient Insert Leaflet · PI = Product Information
| Product | Indication | SPC | PIL |
|---|---|---|---|
| Aciq® | Fentanyl, Breakthrough pain | SPC | PIL |
| Aggrastat® (Tirofiban) | Antiplatelet | SPC | — |
| AmbiFul® (Fulvestrant) | Metastatic hormone receptor-positive breast cancer | SPC | — |
| Brinavess® (Vernakalant) | Anti-arrhythmic | SPC | — |
| Coldistop® | Nasal oil | SPC | PIL |
| Cuprior® (Trientin) | Wilson's disease | SPC | PIL |
| Cyanokit® (Hydroxocobalamin) | Cyanide poisoning | SPC | — |
| DigiFab® (Digoxin Immune FAB) | Digoxin toxicity | — | — |
| Effentora® | Fentanyl, Breakthrough pain | SPC | PIL |
| Effortil (Etilefrinhydrochlorid) | Antihypotensive | SPC | PIL |
| elmiron® (Pentosan Polysulfate) | Bladder pain syndrome / interstitial cystitis | SPC | PIL |
| Erythrocin® (Erythromycin) | Antibioticum | SPC | — |
| Fluoresceine 0,5% | Diagnostic ophthalmology | SPC | — |
| Fluoresceine 10% | Diagnostic ophthalmology | SPC | — |
| Foscavir® (Foscarnet) | Antiviral | SPC | — |
| Fucithalmic® (Fusidic acid) | Ophthalmic / Antibioticum | SPC | PIL |
| Garamycin® Schwamm | Gentamycin collagen sponge | SPC | — |
| Hytrin® BPH (Terazosinum) | Benign prostatic hyperplasia | SPC | PIL |
| Imukin® (human Interferon gamma 1b) | Immunomodulator | SPC | — |
| Mysoline® (Primidone) | Epilepsy and essential tremor | SPC | PIL |
| Néo-Mercazole® (Carbimazolum) | Thyreostatic | SPC | PIL |
| Nityr® (Nitisinon) | Hereditary tyrosinemia type 1 | SPC | PIL |
| Nootropil® (Piracetam) | Nootropic | SPC | PIL |
| Proleukin® (Aldesleukine) | Immunomodulator | SPC | — |
| Propycil® (Propylthiouracil) | Thyreostatic | SPC | PIL |
| Psychopax® (Diazepam) | Tranquilizer | SPC | PIL |
| Pylori 13 | Helicobacter pylori test | SPC | — |
| Renacet (Calcium Acetate) | Phosphate binder | SPC | PIL |
| Renapro, Renergy | Special nutrition for dialysis patients | — | PIL |
| Sicorten® (Halometasonum) | Dermato corticosteroid | SPC | PIL |
| Succicaptal® (Succimer) | Treatment of lead and mercury poisoning | SPC | — |
| Synacthen® (Tetracosactidum) | Corticostimulin | SPC | — |
| ULTRASTOP® | Anti-fog agent | — | — |
| Xenazine® (Tetrabenazine) | Chorea associated with Huntington's disease | SPC | PIL |
| Zonegran® (Zonisamid) | Antiepileptic | SPC | PIL |
Commercial Partnerships for Switzerland
Curatis is your partner of choice for pharmaceutical products in Switzerland. We offer customised and efficient partnership packages for the commercialisation of pharmaceutical products, taking into account the specific needs and requirements of the partner company and its product(s).
Specialty & Orphan Drugs
Specialty care drugs, orphan drugs, and antidotes
Market Access
Registration, pricing, and reimbursement services
Marketing & Sales
Targeted marketing and sales activities for specialised products
Early Access Programmes
Facilitating patient access before full market authorisation
Quality & Pharmacovigilance
State-of-the-art quality and pharmacovigilance know-how
Efficient Operations
Fast operational processes and communication with partners
Partner-Specific Solutions
Accommodation and implementation of partner-specific requirements
Commercial Partnerships for Germany, France, United Kingdom, Italy
In line with the company's geographic expansion strategy, Curatis is also looking for distribution partnerships for ultra orphan, orphan, and specialty care medicines in Germany, France, Italy, and the UK.
Get in Touch